Latin America

Bessemer Venture Partners is a leading venture capital firm that partners with entrepreneurs from their early days through every stage of growth. With a history rooted in the Carnegie Steel empire, Bessemer has a long tradition of investing in transformative companies across various industries. The firm is committed to supporting entrepreneurs with capital, strategic guidance, and a robust network to build enduring companies.

KKR is a leading global investment firm founded in 1976, known for its pioneering role in the private equity industry. The firm is committed to delivering strong returns and shared success to its clients and the world at large. KKR invests across various asset classes, including private equity, infrastructure, real estate, and credit, with a focus on fortifying companies and communities. The firm emphasizes a culture of shared ownership and long-term value creation, aligning its interests with those of its investors and portfolio companies.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.

Camino Real Capital Partners, LLC (CRCP) is a private investment firm based in Santa Fe, New Mexico, dedicated to investing in America's leading innovators and emerging technologies. The firm emphasizes building relationships, fostering growth opportunities, and creating value. CRCP focuses on transformative technology, emerging medical devices, life science innovations, and cutting-edge service providers in the energy sector. The firm invests its own capital alongside a network of accredited co-venturers, providing technology and marketing insights and management guidance to early-stage innovators.

Mitsui & Co. Global Investment, Inc. is a venture capital firm with over 20 years of experience, focusing on guiding entrepreneurs onto the global stage. The firm goes beyond financial support, offering strategic guidance and leveraging its vast network to facilitate key partnerships. With a commitment to improving human welfare, Mitsui partners with exceptional teams to reinvent industries worldwide.

Norwest Venture Partners is a multi-stage investment firm with a history of delivering top quartile returns over the past 60 years. The firm focuses on partnering with founder-managed or capital-efficient businesses, helping them scale from double-digit to triple-digit revenues. Norwest has navigated various economic cycles and remains committed to building strong relationships with its portfolio companies, emphasizing trust and cultural alignment.

Mercury Fund is an early-stage venture capital platform focused on transformative software startups across America. With a mission to drive exceptional outcomes for founders and investors, Mercury Fund emphasizes supporting underrepresented entrepreneurial communities. The firm has created over $9 billion in value through its operationally-focused investment strategy, partnering with both first-time and seasoned entrepreneurs to leverage growth networks and achieve sustainable growth.

SoftBank Vision Fund is a leading venture capital firm that believes in the transformative power of technology. The firm focuses on supporting a full-stack AI technology ecosystem, investing in hardware, infrastructure, and applications to drive innovation across various sectors. With a mission to back ambitious founders with scalable visions, SoftBank Vision Fund aims to create meaningful impact through long-term investments.

Rosetta Capital is a UK-based venture capital firm specializing in the life sciences and medical device sectors. With a global investment approach, the firm focuses on building leading healthcare companies and breakthrough technologies that enhance human lives. Rosetta Capital primarily invests through direct secondary transactions, providing flexible liquidity solutions to investors and corporations. Over its 20+ year history, the firm has made over 50 venture investments, demonstrating extensive expertise in executing complex transactions efficiently.

Ampersand Capital Partners is a middle-market private equity firm founded in 1988, specializing in growth-oriented investments in the healthcare sector. With offices in Boston and Amsterdam, the firm leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams. Ampersand is dedicated to empowering its portfolio companies, partnering closely with founders and leadership teams to build value together, particularly in the life sciences sector.

Western Technology Investment (WTI) is a pioneering venture debt firm that has been providing capital to startups since 1980. With a focus on minimizing dilution, WTI has supported over 1,400 companies across major innovation sectors. The firm is known for its flexible, scalable, and partner-driven approach, offering debt capital from the seed stage through to public listing. WTI is currently investing from its 11th institutional fund, backed by institutional LPs including endowments, non-profits, academic institutions, and select family offices.

UTEC, founded in 2004, is a venture capital firm that collaborates with universities and research institutions globally, focusing on science and technology to create new industries that address global and human challenges. With a strong emphasis on seed and early-stage investments, UTEC has managed five funds totaling approximately 850 billion yen, investing in over 150 startups, with 20 achieving IPOs and 20 undergoing M&A. UTEC's mission is to leverage capital, talent, and knowledge to solve world and human issues through innovative startups.

Longitude Capital is a venture capital firm specializing in venture growth investments in biotechnology, medical technology, and health solutions companies. The firm focuses on improving clinical outcomes, enhancing patient quality of life, and reducing the cost of care. Since its inception in 2006, Longitude Capital has raised over $2 billion across six funds, demonstrating a strong track record in sourcing, managing, and exiting investments across various market cycles. The firm employs a balanced portfolio strategy, investing in clinical-stage and commercial-stage companies with clinically de-risked assets and favorable valuations. Longitude Capital leverages its extensive industry network and proprietary research to identify new investment opportunities and utilizes a variety of investment structures to optimize returns for stakeholders.

Mission BioCapital is a venture capital firm dedicated to empowering life science entrepreneurs by providing early-stage capital and a collaborative platform to realize their visions. Founded in 2009, the firm focuses on transformative investments in life sciences, including therapeutics, diagnostics, medical devices, and drug delivery. With a commitment to mentorship, innovation, and support, Mission BioCapital partners with life sciences incubators to offer shared lab spaces and strategic guidance, helping startups progress from idea to exit.

Bain Capital Life Sciences, founded in 2016, leverages Bain Capital's extensive history in healthcare and life sciences investing. The firm focuses on investing in biopharmaceutical, medical device, diagnostic, and life science tool companies globally, aiming to drive medical innovation and improve the lives of patients with unmet medical needs. With a team of over 25 professionals, Bain Capital Life Sciences provides strategic support to clinical and commercial-stage companies, facilitating critical phases of value creation.

Novo Holdings is a leading holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation, one of the world’s largest enterprise foundations. The company is the controlling shareholder of Novo Nordisk and Novonesis and manages a diverse investment portfolio with a long-term return perspective. Novo Holdings invests in life science companies at all stages of development and manages a broad portfolio of equities, bonds, real estate, infrastructure assets, and private equity investments. The firm is committed to improving people’s health and the sustainability of society and the planet by generating attractive long-term returns.